European Archives - Page 226 of 1151 - European Medical Journal

Long-Term Effects of Recurrent Rejection on Paediatric Heart Transplant Outcomes

Analysis of recurrent rejection (RR) in paediatric heart transplant recipients revealed that 17% of the population studied experienced RR.

24-Hour Antibiotic Course Prevents Infection Post-Cystectomy

A recent single-centre, randomised, trial has explored the effects of a 24-hour perioperative antibiotic course for patients undergoing cystectomy.

Air Pollution's Role in Rising Global Asthma Cases

Recent studies and meta-analyses have investigated the impact of PM2.5 on asthma, yet findings remain inconsistent.

AI Model Matches Radiologists in Detecting Chest X-Ray Abnormalities

A commercially available AI model has been found to perform on par with radiologists in detecting chest X-ray abnormalities.

Semaglutide Reduces Risk of Alzheimer’s Disease

Compared to other anti-diabetic drugs, semaglutide, also known as Ozempic, may lower the risk of Alzheimer’s disease in people with Type 2 diabetes (T2D).

5 stars

Boehringer, Amgen and Novartis rank top for cardiovascular patient groups

Boehringer Ingelheim, Amgen and Novartis have been awarded the highest reputation scores by several cardiovascular patient advocacy groups.

Sustainable pharma packaging takes a big step forward

UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.

Promising Results for CAR T-Cell Therapy in Relapsed T-Cell Acute Lymphoblastic Leukaemia

A breakthrough study has reported encouraging outcomes using autologous chimeric antigen receptor T cells in patients with relapsed or refractory T-cell acute lymphoblastic leukaemia.

AI Tool to Help Diagnose Type 1 Diabetes Early in Children

Researchers at Cardiff University have developed an AI tool that could help detect signs of Type 1 diabetes in children before they experience dangerous complications.

New Test Simplifies the Diagnosis of Allergies

The Hoxb8 mast cell activation test (Hoxb8 MAT) shows high diagnostic accuracy in identifying peanut allergies.